Similar articles for PMID: 21852991

Year	Number of Results
2001	2
2002	3
2004	5
2005	6
2006	5
2007	8
2008	2
2009	13
2010	6
2011	9
2012	4
2013	5
2014	7
2015	8
2016	5
2017	4
2018	1
2019	4
2020	3
2022	1
2024	0

1

A randomized, open-label assessment of response to various doses of atomoxetine in korean pediatric outpatients with attention-deficit/hyperactivity disorder.

Cho S, Lee SI, Yoo H, Song DH, Ahn DH, Shin DW, Yum SY, Walton R, Mendez L. Cho S, et al. Psychiatry Investig. 2011 Jun;8(2):141-8. doi: 10.4306/pi.2011.8.2.141. Epub 2011 Jan 19. Psychiatry Investig. 2011. PMID: 21852991 Free PMC article.

2

Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder.

Montoya A, Hervas A, Cardo E, Artigas J, Mardomingo MJ, Alda JA, Gastaminza X, García-Polavieja MJ, Gilaberte I, Escobar R. Montoya A, et al. Curr Med Res Opin. 2009 Nov;25(11):2745-54. doi: 10.1185/03007990903316152. Curr Med Res Opin. 2009. PMID: 19785510 Clinical Trial.

3

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ. Kelsey DK, et al. Pediatrics. 2004 Jul;114(1):e1-8. doi: 10.1542/peds.114.1.e1. Pediatrics. 2004. PMID: 15231966 Clinical Trial.

4

Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies.

Dickson RA, Maki E, Gibbins C, Gutkin SW, Turgay A, Weiss MD. Dickson RA, et al. Child Adolesc Psychiatry Ment Health. 2011 May 11;5:14. doi: 10.1186/1753-2000-5-14. Child Adolesc Psychiatry Ment Health. 2011. PMID: 21569378 Free PMC article.

5

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP. Purper-Ouakil D, et al. Encephale. 2005 May-Jun;31(3):337-48. doi: 10.1016/s0013-7006(05)82399-1. Encephale. 2005. PMID: 16142049 Review. French.

6

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Quintana H, et al. Clin Ther. 2007 Jun;29(6):1168-77. doi: 10.1016/j.clinthera.2007.06.017. Clin Ther. 2007. PMID: 17692731 Clinical Trial.

7

Open-label, dose-titration tolerability study of atomoxetine hydrochloride in Korean, Chinese, and Taiwanese adults with attention-deficit/hyperactivity disorder.

Takahashi M, Goto T, Takita Y, Chung SK, Wang Y, Gau SS. Takahashi M, et al. Asia Pac Psychiatry. 2014 Mar;6(1):62-70. doi: 10.1111/j.1758-5872.2012.00204.x. Epub 2012 Jul 23. Asia Pac Psychiatry. 2014. PMID: 23857916 Clinical Trial.

8

Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder.

Lee SI, Song DH, Shin DW, Kim JH, Lee YS, Hwang JW, Park TW, Yook KH, Lee JI, Bahn GH, Hirata Y, Goto T, Takita Y, Takahashi M, Lee S, Treuer T. Lee SI, et al. Asia Pac Psychiatry. 2014 Dec;6(4):386-96. doi: 10.1111/appy.12160. Epub 2014 Oct 27. Asia Pac Psychiatry. 2014. PMID: 25345739 Clinical Trial.

9

Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder.

Geller D, Donnelly C, Lopez F, Rubin R, Newcorn J, Sutton V, Bakken R, Paczkowski M, Kelsey D, Sumner C. Geller D, et al. J Am Acad Child Adolesc Psychiatry. 2007 Sep;46(9):1119-1127. doi: 10.1097/chi.0b013e3180ca8385. J Am Acad Child Adolesc Psychiatry. 2007. PMID: 17712235 Clinical Trial.

10

Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine.

Thome J, Dittmann RW, Greenhill LL, Lipsius S, Tanaka Y, Bushe C, Escobar R, Heinloth AN, Upadhyaya H. Thome J, et al. Atten Defic Hyperact Disord. 2017 Dec;9(4):219-229. doi: 10.1007/s12402-017-0227-8. Epub 2017 May 5. Atten Defic Hyperact Disord. 2017. PMID: 28477289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year